Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Arther Morely-Bunker

Postdoctoral Fellow

MSc(Ulster), PhD(Otago)

 

Email arthur.morley-bunker@otago.ac.nz

Research interests

Dr Arthur Morley-Bunker is investigating cytomegalovirus and Epstein-Barr virus in breast cancer tissue samples.

Dr Morley-Bunker recently completed his PhD by scoping for RNA biomarkers of colorectal cancer cases under the supervision of Dr Logan Walker, Dr John Pearson, Associate Professor Tim Eglinton and Dr Margaret Currie.

^ Top of page

Publications

Morley-Bunker, A., Pearson, J., Currie, M. J., Morrin, H., Whitehead, M. R., Eglinton, T., & Walker, L. C. (2019). Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation. Oncotarget, 10(14), 1425-1439. doi: 10.18632/oncotarget.26675

Lattimore, V. L., Pearson, J. F., Morley-Bunker, A. E., kConFab Investigators, Spurdle, A. B., Robinson, B. A., Currie, M. J., & Walker, L. C. (2019). Quantifying BRCA1 and BRCA2 mRNA isoform expression levels in single cells. International Journal of Molecular Sciences, 20(3), 693. doi: 10.3390/ijms20030693

Morley-Bunker, A., Pearson, J., Currie, M., Morrin, H., Whitehead, M., Eglinton, T., & Walker, L. (2018). Intratumoural assessment of candidate colorectal cancer prognostic markers using RNA in situ hybridization. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Morley-Bunker, A., Walker, L. C., Currie, M. J., Pearson, J., & Eglinton, T. (2016). Translating colorectal cancer genetics into clinically useful biomarkers. Colorectal Disease, 18(8), 749-762. doi: 10.1111/codi.13334

Morley-Bunker, A., Miller, A., & Neal, H. (2010). Validation of the BD FocalPointTM GS Imaging System for cervical screening by Canterbury Health Laboratories, New Zealand. Acta Cytologica, 54(3, Suppl.), (pp. 481-482). [Abstract]

Journal - Research Article

Morley-Bunker, A., Pearson, J., Currie, M. J., Morrin, H., Whitehead, M. R., Eglinton, T., & Walker, L. C. (2019). Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation. Oncotarget, 10(14), 1425-1439. doi: 10.18632/oncotarget.26675

Lattimore, V. L., Pearson, J. F., Morley-Bunker, A. E., kConFab Investigators, Spurdle, A. B., Robinson, B. A., Currie, M. J., & Walker, L. C. (2019). Quantifying BRCA1 and BRCA2 mRNA isoform expression levels in single cells. International Journal of Molecular Sciences, 20(3), 693. doi: 10.3390/ijms20030693

Morley-Bunker, A., Walker, L. C., Currie, M. J., Pearson, J., & Eglinton, T. (2016). Translating colorectal cancer genetics into clinically useful biomarkers. Colorectal Disease, 18(8), 749-762. doi: 10.1111/codi.13334

^ Top of page

Conference Contribution - Published proceedings: Abstract

Morley-Bunker, A., Pearson, J., Currie, M., Morrin, H., Whitehead, M., Eglinton, T., & Walker, L. (2018). Intratumoural assessment of candidate colorectal cancer prognostic markers using RNA in situ hybridization. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Morley-Bunker, A., Miller, A., & Neal, H. (2010). Validation of the BD FocalPointTM GS Imaging System for cervical screening by Canterbury Health Laboratories, New Zealand. Acta Cytologica, 54(3, Suppl.), (pp. 481-482). [Abstract]

^ Top of page

Conference Contribution - Poster Presentation (not in published proceedings)

Morley-Bunker, A., Miller, A., & Neal, H. (2010, May). Validation of the BD FocalPointTM GS Imaging System for cervical screening by Canterbury Health Laboratories, New Zealand. Poster session presented at the 17th International Congress of Cytology, Edinburgh, Scotland.

More publications...